Duke University Immunologist Buckley Is Cited For Transplantation Research

Rebecca H. Buckley, J. Buren Sidbury Professor of Pediatrics and chief of pediatric allergy and immunology at Duke University Medical Center, Durham, N.C., has received the 29th annual National Board Award, recognizing a woman scientist or physician who has made significant contributions to health care. It is presented by the Philadelphia-based Medical College of Pennsylvania, the United States' first medical school for women. Buckley received the college's Presidential Medal and a $5,000 resea

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Buckley, 58, developed bone marrow transplant therapies for severe combined immunodeficiency disease (SCID). Before her work in 1982, only perfectly matched siblings of SCID infants could be bone marrow donors. Most afflicted babies did not have matched donors.

"It was horrible because they all died within a few weeks of being diagnosed," Buckley says.

In 1982, Buckley and colleagues found that transplants involving stem cells rather than mature T cells pose little threat of graft-versus-host disease (Journal of Immunology, 136:2398-2407, 1986). Since that discovery, Buckley has reported that her group has been able to save about 75 percent of 45 marrow-transplant infants without matched donors.

Buckley is also known for her work in allergic diseases. She published the first report of hyperimmunoglobulinemia E, also known as Buckley syndrome (Pediatrics, 49: 59-70, 1972). "People joke about it and say it's just a trivial problem--but that's a misconception that people have," she ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Barbara Spector

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio